Professional
Added to YB: 2021-05-03
Pitch date: 2021-05-03
PDRX [bullish]
PD-Rx Pharmaceuticals, Inc.
Author Info
Cedar Creek Partners provides deep-dive research on undervalued companies. Follow on Twitter/X.
Company Info
PD-Rx Pharmaceuticals, Inc. engages in the repackaging and distribution of prepackaged pharmaceutical products for the healthcare industry in the United States.
Market Cap
$8.2M
Pitch Price
$2.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
-27.03
P/E
-83.33
EV/Sales
0.07
Sector
Health Care Providers and Services
Category
value
Cedar Creek Partners increased position - PD-Rx Pharmaceuticals (PDRX)
PDRX: Increased to 4.5% fund position in Q1, bought $2.60-$2.75/share. Jun '20: $4 book value/share, no debt except PPP loan, $2.02 net cash/share. Small FY20 loss but significant discount to book, high cash (cash+receivables-liabilities > price paid), cost cuts not yet reflected.
Read full article (2 min)